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In Brief Yao et al. provide evidence that MYORG is a major causal gene for autosomal recessive PFBC by a comprehensive strategy combining whole-exome sequencing analysis, Sanger sequencing, linkage analysis, RNA expression analysis, and a mouse model.
INTRODUCTION
The prevalence of brain calcification increases with age, from $1% in young adult to more than 20% in the elderly (Nicolas et al., 2013a; Taglia et al., 2014) . Primary familial brain calcification (PFBC), previously known as idiopathic basal ganglia calcification (IBGC) or Fahr's disease, has been attracting increasing research attention in recent years. PFBC is a genetic disorder characterized by bilateral calcifications in the basal ganglia, cerebellum, thalami, and subcortical white matter (Nicolas et al., 2013a) . Histopathological examination of PFBC reveals that calcium deposits are predominantly distributed around blood vessels (Miklossy et al., 2005; Wider et al., 2009) . Although mild calcification is usually asymptomatic, patients with severe brain calcification show a wide spectrum of clinical manifestations, including chronic progressive movement disorders, cognitive impairment, and psychiatric symptoms. Typically, PFBC is inherited in a dominant pattern and heterozygous mutations of the four genes (SLC20A2, PDGFRB, PDGFB, and XPR1) have been identified (Keller et al., 2013; Legati et al., 2015; Nicolas et al., 2013b; Wang et al., 2012) . Moreover, although biallelic mutations in ISG15 were reported in patients with brain calcifications and abnormal interferon (IFN)-a/b immunological response (OMIM 616126) (Zhang et al., 2015) , their clinical presentations do not satisfy the diagnosis criteria of typical PFBC (Ramos et al., 2017) . The genetic basis of half of PFBC families, as well as the molecular and cellular mechanisms, is still unknown (Taglia et al., 2015) .
Utilizing a comprehensive strategy combining whole-exome sequencing (WES) analysis, Sanger sequencing, linkage analysis, RNA expression analysis, and a mouse model, we provide evidence that myogenesis regulating glycosidase (MYORG) (NCBI Gene57462; NM_020702) is a causal gene for PFBC.
RESULTS

Identification of Biallelic Mutations in MYORG in Six
Autosomal Recessive PFBC Families For our study, we recruited 51 PFBC families and sequenced the four known PFBC genes (SLC20A2, PDGFB, PDGFRB, and XPR1). Pathogenic mutations were found in 27 (52.9%) families. To determine the causal genes for the remaining families, we first performed WES in a consanguineous family (family 1) that had two PFBC patients (V7 and V9) who exhibited speech impairment, ataxia, and obvious calcification in the globus pallidus and cerebellum (Figures 1A and S1; Table S1 ). WES was performed for the two affected brothers (V7 and V9) and one unaffected sibling (V5). Because of the assumed recessive mode of inheritance in this family, we searched for homozygous mutations in the genome that were shared by the two affected but were not completely shared by the unaffected sibling. This (Table  S2) . We then studied a second family that was also consistent with the recessive mode of inheritance (family 2). Both the proband (III4) and his brother (III6) presented highly similar calcification patterns to that of family 1 (Figures 1A and S1 ; Table S1 ). Their parents (II3, II4), however, had negative brain CT scans. We performed WES analysis for these two affected brothers and one unaffected sibling (III5). We searched for genes with compound heterozygous or homozygous variants in the affected brothers but not in the unaffected sister. This strategy led to the discovery of two genes, MYORG (a truncating mutation c.1328G > A [p.W443*] and a missense variant c.103A > G [p.M35V]) and SHISA6 (two missense variants) (Table S2) .
Because MYORG was the only gene implicated in both families, we then sequenced the entire coding regions of MYORG by Sanger sequencing in probands from eight additional PFBC families consistent with a recessive mode of inheritance and three pedigrees with an uncertain mode of inheritance. Homozygous or compound heterozygous mutations in MYORG were identified in four additional probands (Figures 1A and S1 ; Table 1 ). For the remaining seven families, we did not detect any suspected heterozygous or homozygous pathogenic mutations in MYORG.
To assess co-segregation of MYORG mutations with the brain calcification phenotype, we Sanger sequenced the gene for all members of each of these six families whose DNA samples were available and then performed a two-point linkage analysis. For the disease locus (calcification phenotype, qualitative), a rare recessive mode of inheritance was assumed: the disease allele frequency was 0.01, and penetrance for the homozygous normal allele, the heterozygous allele, and the homozygous disease allele was 0.001, 0.999, and 0.999, respectively. For the marker locus, any pathogenic MYORG mutation was coded as 1, otherwise, 0. A complete co-segregation between the brain calcification phenotype and MYORG mutations was found, with an overall logarithm of odds (LOD) score of 4.91 at the zero recombination fraction. See also Figures S1-S3 and Tables S1, S2 , and S4. The frequency of the mutation in total population was calculated by mutated allele number/total allele number in parentheses d The frequency of the mutation in East Asian population was calculated by mutated allele number/total allele number in parentheses
Of the nine identified MYORG mutations ( Figure S2 ) in the above six pedigrees, three were nonsense mutations (p.W75*, p.Q203*, and p.W443*), two were insertion or deletion mutations that affected several amino acids (p.116_117insLAFR and p.365_366delFD), and four were missense mutations all located in the highly conserved domains (p.M35V, p.S232L, p.R261L, and p.R441G) ( Figure S3 ). All of these variants were absent in the 1000 Genomes Project, and the NHLBI GO Exome Sequencing Project (ESP) database. They were also absent or heterozygous at extremely low frequencies in the Genome Aggregation Database (gnomAD) ( Table 1) . A total of 40 stop-gained or frameshift variants were reported in gnomAD; . Ctx, cortex; Hip, hippocampus; Tha, thalamus; Str, striatum; Crb, cerebellum; DG, dentate gyrus; ML, molecular layer; PCL, Purkinje cell layer; GCL, granule cell layer; Roman numerals II-VI indicate cortical layers. (C-F) Combined immunofluorescence and ISH in the mouse brain. Slices of the cortex (C) and cerebellum (D) incubated with Myorg RNA probe (red) and S100b antibody (green). (E) Co-immunostaining of GFP (green) and S100b (red) of brain slices from Myorg-GFP knockin mice. (F) Double fluorescence labeling of Myorg (RNA probe) and GFAP (antibody) in mouse hippocampus (left), and dual ISH of Myorg (green) with either Ng2 (red, middle) or Pdgfrb (red, right) in mouse cortex. GCL, granule cell layer. (G) Cos-7 cells and primary cultured human astrocytes were transfected with EGFP-tagged MYORG and immunostained with antibodies against GFP (green) and either the ER marker Calnexin (red, right) or the Golgi marker GM130 (red, left). DAPI (blue) was used for nuclear staining. Scale bar, 500 mm in (A), 100 mm in (B), 25 mm in (C)-(F), and 5 mm in (G). See also Figure S4 .
however, all of them were heterozygous and had very low allele frequencies (Table S3) . We also sequenced the entire coding regions of MYORG in 1,000 healthy controls without brain calcification and did not detect any nonsense, compound heterozygous, or homozygous mutations. Overall, MYORG mutations accounted for 11.8% (6/51) of PFBC families in our cohort, and 46.2% (6/13) of PFBC families with apparent recessive mode of inheritance, rendering MYORG as a major cause of PFBC.
Generally, calcification severity of PFBC patients within or between families differs considerably (Manyam et al., 2001; Taglia et al., 2014) . In contrast, patients with MYORG mutations showed highly similar calcification patterns. Among the 12 patients (7 male, 5 female), most of them exhibited severe calcification in the basal ganglia (12/12) and dentate nuclei (12/12), as well as in the thalamus (8/12) and subcortical white matter region (9/12), without gender bias ( Figure S1 ; Table S1 ). Moreover, patients with MYORG mutations also presented highly similar clinical features. Six had similar symptoms including slurred speech (6/6), ataxia (5/6), and chorea (1/6). Additionally, two patients showed migraines, and the other four patients seemed asymptomatic (Table S1 ). Furthermore, among the four probands (Table S4) , three presented with ataxia and mild to moderate cognitive decline as measured by the International Cooperative Ataxia Rating Scale (ICARS) and Mini Mental State Examination (MMSE). We observed that patients with homozygote truncating mutations had more severe symptoms; however, long-term follow-up in larger studies is needed to confirm this observation.
The gene MYORG, previously known as KIAA1161 or NET37, is located on chromosome 9p13.3 and encodes a 714-aminoacid protein that is a member of the glycosyl hydrolase 31 family. To date, little is known about the function of MYORG. The MYORG protein contains a single transmembrane domain at its N terminus (aa 57-77) and a predicted family 31 glycosyl hydrolase domain (aa 311-714) at its C terminus ( Figure 1B ). Mutations identified in this study were distributed throughout all the coding regions of MYORG gene. Seven of the nine (D) EDS analysis revealed that the main elements of the nodule (red) were calcium (Ca), phosphorus (P), and oxygen (O). The gold peak (Au) in the surrounding tissues (black) resulted from the process of gold sputtering for electric conduction in SEM. Images were representative of analyses made on three mice for each group. Scale bar, 500 mm in (A), 100 mm in (B), and 25 mm in (C).
disease-associated mutations resided in the endoplasmic reticulum (ER) luminal fragment, with three in the glycosidase domain. The remaining variants, p.M35V and p.W75*, were mapped to the cytoplasmic and transmembrane fragments, respectively ( Figure 1B ).
Specific Expression of MYORG in Astrocyte ER
Previous in vitro studies showed that the myocyte-expressing Myorg was involved in myogenesis (Chen et al., 2006; Datta et al., 2009 ). However, the cellular basis underlying the association of MYORG with PFBC remains unclear. We measured the tissue expression pattern of Myorg mRNA in C57BL/6J mice using real-time PCR and found a ubiquitous expression of Myorg in mouse tissues ( Figure S4 ). In the brain, Myorg mRNA was highly expressed in the cerebellum, which is commonly affected by calcium deposit in patients. We further analyzed Myorg expression in the mouse brain by in situ hybridization (ISH). Generally, Myorg expression was found to be dispersed all over the brain ( Figure 2A ). Particularly, Myorg expression signals were enriched in cells with smaller soma (Bergmann glia) within the Purkinje cell layer (PCL) of the cerebellum, raising the speculation that Myorg was specifically expressed in astrocytes ( Figure 2B ). To confirm this, we coupled Myorg ISH with methods to label astrocytes (S100b, GFAP), oligodendrocytes (Ng2), and pericytes (Pdgfrb). We observed pronounced colocalization of Myorg in situ signals with S100b immunostaining throughout the brain, including the cerebral cortex ( Figure 2C ) and cerebellum ( Figure 2D ). Moreover, in the hippocampus, Myorg in situ signals were also co-localized with GFAP immunostaining ( Figure 2F , left). To further verify this result, we generated Myorg-GFP knockin mice, with GFP coding sequence inserted directly after the ATG codon of the endogenous Myorg gene. We found that all GFP-expressing cells also expressed S100b ( Figure 2E ). We only found a partial overlap in expression of Myorg and Ng2 using duplex ISH ( Figure 2F , middle). In contrast, no colocalization was observed between Myorg and Pdgfrb ( Figure 2F, right) . Collectively, these results suggested for the first time that Myorg is specifically expressed in S100b + astrocytes.
To study the subcellular localization of MYORG protein, GFPtagged MYORG plasmid was transfected into both the Cos-7 cells and primary cultured human astrocytes. The GFP-tagged MYORG was mostly localized to the ER, as shown by the colocalization with ER marker protein Calnexin in both cell types ( Figure 2G , right). We only observed partial colocalization of MYORG with Golgi marker protein GM130 ( Figure 2G, left) . Overall, these results indicated that MYORG may regulate protein glycosylation in the ER of astrocytes in the brain.
Knockout of MYORG Caused Calcification Deposits in Mouse Brain
To functionally test the significance of loss-of-function MYORG mutations on brain calcification, we generated Myorg homozygous knockout (KO) mice via a one-step strategy as previously reported Yang et al., 2013; Zuo et al., 2017) . Briefly, two single guide RNAs (sgRNAs) that targeted Myorg and Cas9 mRNA were co-injected into C57BL/6J zygotes. Genotyping of founder mice was performed by sequencing PCR products of Myorg genomic DNA, and the genotypes were further verified by single clone sequencing of each allele after insertion into a T-vector. The existence of calcification deposit was examined monthly beginning at 2 months of age. No obvious brain calcification was detected in either control or Myorg KO mice from the age of 2-8 months. In brain sections of 9-month-old Myorg homozygous KO mice, we detected bilateral irregular calcified spheres that stained positive for alizarin red, Von Kossa, and H&E as well as Alcian blue and periodic acid-Schiff (PAS) in the thalamus ( Figures 3A and 3B, upper) . These calcified nodules were spherical or oval with a diameter of 10-50 mm. In contrast, no calcified nodules were observed in the brain of control mice at this age ( Figure 3B, lower) .
We further analyzed the element composition of these spheres using scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM-EDS) ( Figure 3C ). The main compositions of these spheres were calcium, phosphorus, and oxygen, in contrast to carbon in the surrounding tissues, suggesting that the majority of the deposited nodules were calcium phosphate ( Figure 3D ). The components of calcification in Myorg KO mice are qualitatively similar to that in humans (Miklossy et al., 2005) . Conclusively, these results demonstrated that Myorg KO caused the formation of calcium phosphate deposits in the mouse brain, further supporting the notion that MYORG is a causative gene of PFBC.
DISCUSSION
In summary, we identified MYORG as a common PFBC gene and the first autosomal recessive causal gene for PFBC. Furthermore, we showed that Myorg mRNA in mice was specifically expressed in astrocytes, defining astrocytes as a cell type involved in brain calcification. Finally, we showed that Myorg KO mice developed calcium deposits in the brain, which recapitulates the disease phenotype in PFBC patients.
A previous autopsy study indicated that metabolic disturbance and accumulation of acid mucopolysaccharide were the initial changes in brain calcification (Adachi et al., 1968; Kobayashi et al., 1987) . A mixture of polysaccharides, glycoproteins, and mucopolysaccharides may facilitate the formation of calcium deposition. In our study, calcium phosphate depositions were formed in the brain after the removal of the glycosidase MYORG. This suggests that inactivation of the glycosidase function of MYORG may lead to abnormalities in protein glycosylation and metabolism, which may set the ground for brain calcification. Considering that MYORG mutations accounted for about half of the recessive PFBC cases, our finding might unveil a general and critical molecular basis that could initiate brain calcification.
Moreover, we found MYORG was specifically expressed in astrocytes. The endfeet of astrocytes, coupled with pericytes and endothelial cells, form the neurovascular unit (NVU), which is closely associated with brain calcification deposits (Betsholtz and Keller, 2014; Kobayashi et al., 1987; Miklossy et al., 2005) . Consequently, MYORG mutations cause dysfunction of astrocytes, which may affect the association between astrocytes and pericytes, and disturb normal function of the NVU, leading to the formation of calcified nodules. Previously, blood-brain barrier (BBB) disruption caused by impaired pericyte recruitment in PDGFB or PDGFRB mutant mice or patients was found to be a critical cellular mechanism underlying brain calcification (Keller et al., 2013; Nicolas et al., 2013b) . Taken together, these findings point to a central hypothesis that brain calcification arises from dysfunction of the NVU. Future studies are needed to investigate the detailed molecular and cellular mechanism.
It is worth mentioning that dysfunction of the NVU is also shared by major neurodegenerative diseases as a common cellular pathological change preceding the occurrence of behavioral symptoms (Bell et al., 2010; De Strooper and Karran, 2016; Ransohoff, 2016) . Considering that 45% of Down syndrome patients, over 20% of Parkinson's disease (PD) patients, and 10% of Alzheimer's disease (AD) patients were found to develop brain calcifications (Takashima and Becker, 1985; Vermersch et al., 1992) , and they also overlapped in histological pathogenesis and clinical manifestations (Chakrabarty et al., 2011; Hashimoto et al., 2003; Nicolas et al., 2013a) , whether brain calcification has synergistic impact on the progression of major neurodegenerative diseases is an interesting question. Therefore, unveiling the genetic basis and associated mechanisms of brain calcification should also promote the understanding of the pathogenic mechanisms underlying many neurodegenerative diseases.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Subjects
The recruited PFBC families have a nationwide geographic distribution. The criteria for the diagnosis of PFBC were as follows: a). the calcifications detected by CT scans are bilateral and symmetrical in basal ganglia and/or dentate nucleus; b). a total calcification score (TCS) rates above the age-specific thresholds determined as previously reported (Nicolas et al., 2013a) ; c). absence of biochemical abnormalities, with normal serum concentration of calcium, phosphorus, and parathyroid hormone (PTH); d). absence of an infectious, toxic, or traumatic cause. All the patients received a complete neurological examination by two neurologists, a CT scan and laboratory tests. Some symptomatic patients were also evaluated with the corresponding neuropsychological test battery including the International Cooperative Ataxia Rating Scale (ICARS), Mini Mental State Examination (MMSE), Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) by neurologists who were blinded to the patients' genotype. Totally, 51 PFBC families were recruited in this study. We first screened for mutations in SLC20A2, PDGFRB, PDGFB and XPR1 using Sanger sequencing in all probands. The demographics of patients with MYORG biallelic mutations can be found in Table S1 . Moreover, one thousand calcification-negative controls (625 male, 375 female, mean age 61.6 ± 15.3 years) verified by CT scans from in-patient department of the First Affiliated Hospital of Fujian Medical University were also enrolled. Strategies of randomization and sample size determination were not applicable to this study. This study was approved by the institutional review board at the First Affiliated Hospital of Fujian Medical University. All participants gave their written informed consent prior to inclusion.
Animals
All mice were maintained in the animal facility of Institutes of Neuroscience, Chinese Academy of Sciences. Mice were housed in a standard 12 h light/dark cycle with free access to standard rodent chow and water. A mixture of male and female mice were employed in all studies and no differences between sexes were observed. All animal experiments were performed according to the institutional guidelines for the Care and Use of Laboratory Animals and were approved by the ethical committee of Institute of Neuroscience, Chinese Academy of Sciences. For the generation of Myorg homozygous KO mice, a one-step approach was employed as previously described (Zuo et al., 2017) . Briefly, two different sgRNAs sequences (sgRNA1 5 0 -CTGCTGTGCTCCGCGGTACT-3 0 and sgRNA2 5 0 -TTCTCCATCCGTAACC AGAA-3 0 ), targeting different genomic loci of Myorg (position c.166-185 and position c.295-314) were used to generate early frameshift mutations. The mRNA of sgRNAs and Cas9 were synthesized by in vitro transcription kits (MEGAshortscript T7 Transcription Kit for sgRNAs and mMESSAGE mMACHINE T7 ULTRA Transcription Kit for Cas9), and then co-injected at a concentration of 100ng/ml into C57BL/6J zygotes. Qualified zygotes at blastocyst stage were subsequently implanted into surrogate female mice. Tail genomic DNA of 100 mice at postnatal day 5 was extracted, and PCR-amplified using a pair of primer targeting Myorg: (Forward 5 0 -GCAACCATGTACACTTTCCTGCCT-3 0 and Reverse 5 0 -ACTGTCTGAATAAAGAAGTGCAACG-3 0 ). The PCR products were purified with the GenElute PCR clean-up kit (Sigma, Billerica, USA) and cloned into the TA Cloning Vector. At least 20 clones for each mouse sample were sequenced for the analysis of Myorg mutation pattern. Only homozygous KO mice were used for the examination of brain calcification. Both male and female adult Myorg KO mice were used for experimental studies.
For the generation of Myorg-GFP knockin mice, the coding sequence of green fluorescent protein was knocked in directly after the ATG start codon of the endogenous Myorg gene (Biocytogen., Beijing, China), thus also leads to absent expression of endogenous Myorg. Briefly, a targeting sequence of EGFP-WPRE-polyA cassette bilaterally flanked by 1.5kb homologous arm, together with the mRNA of Cas9 and sgRNA with targeting sequence (5 0 -TTGGCAGGTGAAAAATTGTC-3 0 , exon 2 of Myorg) were mixed and co-injected into C57BL/6J zygotes to generate knockin offspring. Founders genotyped with correct knockin, and no random insertions verified by Southern blotting, was mated with C57BL/6J wild-type mice for two generations before experimental analysis. Genotyping of offspring was performed by PCR of genomic DNA using primers to detect either the wild-type (Forward 5 0 -TGGGGCCTGAGA GAAACGAGAGTAA-3 0 and Reverse 5 0 -CTTCTGGTTACGGATGGAGAAGCCG-3 0 ) or mutated allele (Myorg-GFP knockin) (Forward 5 0 -CGACCTCGACTGTGCCTTCTAGTTG-3 0 and Reverse 5 0 -CTTCTGGTTACGGATGGAGAAGCCG-3 0 ). For tissue analysis studies, mice were aged between 8-10 weeks.
Cell Culture Primary human astrocytes isolated from human cerebral cortex were purchased from ScienCell Research Laboratories (Cat# 1800, Carlsbad, CA, USA). Human astrocytes were authenticated by immunofluorescence with antibody GFAP by ScienCell Research Laboratories. The sex of human astrocytes was not determined. The Cos-7 was purchased from Shanghai Institute of Biochemistry and Cell Biology (Cat#CBP60927, Chinese Academy of Science) without the specification of sex identity. The Cos-7 cells were authenticated by short tandem repeat (STR) profiling. Both the primary human astrocytes and Cos-7 cells were cultured in DMEM supplemented with 10% FBS in a 5% CO 2 incubator at 37 C under humid atmosphere.
METHOD DETAILS
DNA Extraction and Whole-Exome Sequencing Genomic DNA was extracted from the peripheral blood cells of patients and normal controls using a QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany). Whole exome was captured with SeqCap EZ Exome Kit V3 (Roche Technologies) and sequenced using the Illumina HiSeq 3000 platform. Sequencing reads were obtained in the Fastq format. The reads were mapped to human genome GRCh38 using Burrows Wheeler Aligner (BWA) (Li and Durbin, 2009 ). Variants were called using the Genome Analysis Toolkit (GATK) (McKenna et al., 2010) and annotated with ANNOVAR (Wang et al., 2010) . Variants fulfilled the following criteria were first excluded: a). the variant did not affect the amino acid; b). allele frequency > 1% in 1000 Genomes Project, ESP database or gnomAD. We then screened possible disease-causing genes according to the inheritance pattern.
Sanger Sequencing
Sanger sequencing was performed on the coding exon (exon2) of the MYORG gene (NM_020702) by using the ABI 3700 automated sequencer (Applied Biosystems). A total of four pairs of primers were designed to cover the entire coding regions of MYORG. 
Genetic Linkage Analysis
Linkage analyses were done by the GeneHunter software (Kruglyak et al., 1996) . For the disease locus (calcification phenotype, qualitative), a rare recessive mode of inheritance was assumed. The disease allele frequency was 0.01 and the penetrance for the homozygous normal allele, the heterozygous disease allele, and the homozygous disease allele was 0.001, 0.999, and 0.999, respectively. For the marker locus, any pathogenic MYORG mutation was coded as 1, otherwise, 0.
In Situ Hybridization (ISH)
All the instruments and reagents used in the ISH test were prepared using diethylpyrocarbonate (DEPC). Two-month-old C57BL/6J mice (SLAC, Shanghai, China) were anesthetized by pentobarbital and perfused with 4% PFA in PBS (pH 7.4). The harvested brains were fixed in 4% PFA for another day before consecutive dehydration in 15% and 30% sucrose. Brain slices with 20-mm thickness mounted on Superfrost glass slides (Fisher, USA) were subjected for ISH using the RNAscope 2.5 HD Reagent Kit-BROWN (Advanced Cell Diagnostics, Cat.322310) with the customized mouse Myorg probe (Advanced Cell Diagnostics, Cat.300031) according to the manufacturer's instructions. For duplex hybridization, RNAscope Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics, Cat.323100) was used by combining Myorg probe C1 with either Pdgfrb probe C2 (Advanced Cell Diagnostics, Cat. 411381-C2) or Ng2 probe C3 (Advanced Cell Diagnostics, Cat. 404131-C3). For double labeling combining ISH and immunofluorescence, the slices subjected for ISH with Myorg probe were then incubated with Ab against S100b (1:300, ab868, abcam) or GFAP (1:800, ab53554, abcam). The whole brain expression of Myorg was imaged with 40 3 objective lens using VS120 microscope (Olympus, Japan), and fluorescenct images acquired with 488nm and 568 nm laser were taken by 40 3 objective lens with Z-step of 0.5 mm using Nikon A1R laser confocal microscope. At least three animals were replicated for ISH analysis.
DNA Constructs and Reagents
The full-length MYORG was amplified from pCMV-MYORG-Flag vector (Origene, Rockville, USA) with primers: Forward 5 0 -CTCGAGCTCAAGCTTATGCTCCAGAACCCTCAGG-3 0 and Reverse 5 0 -CGACCGGTGGATCCCGGGACGCCCAGGTAAAG TAGG-3 0 . The GFP tagged MYORG (pEGFP-MYORG) was constructed by cloning the MYORG cDNA into pEGFP-N1 (Clontech) digested with HindIII and BamHI enzymes using ClonExpress One Step Cloning Kit (Vazyme, China). The construct was verified by Sanger sequencing.
Immunocytochemistry (ICC)
For the double-immunofluorescence (IF) staining, brain slices of Myorg-GFP mice were prepared according to the above-mentioned method. The slices were incubated with Ab against GFP (1:2000, ab13970, abcam) and S100b (1:300, ab868, abcam) as markers of astrocytes. Three Myorg-GFP mice was used for this analysis. To test the sub-cellular localization of MYORG, human astrocytes and Cos-7 cells were plated on 10 mm coverslips in 24-well dishes, and transfected at a confluency of 70%-80% with 1 mg/well pEGFP-MYORG plasmid using Lipofectamine 3000 transfection reagent (Invitrogen, USA). Two days later, the coverslips were incubated with Ab against GFP (1:2000, ab13970, abcam), together with either Calnexin (1:1000, ab10286, abcam) as an ER marker or GM130 (1:1000, 610822, BD Bioscience) as a Golgi marker at 4 C overnight. The next day, the slices or coverslips were incubated with corresponding secondary antibodies. For nuclear staining, DAPI was used (Invitrogen). Fluorescence images were acquired using a laser scanning confocal microscope (Nikon, A1R, Japan). This experiment was replicated three times.
RNA Isolation and Real-Time PCR For tissue expression study, 2-month-old C57BL/6J mice were used. Total RNA from different tissues was extracted using TRIzol Reagent. First strand cDNA was generated from 1000ng of total RNA per sample using the iScript cDNA Synthesis kit (Bio-Rad, USA). The sequence of the primer pairs for Real-time PCR is listed as follows: GAPDH Forward 5 0 -ATCCCAGAGCTGAACGG GAAGC-3 0 and Reverse 5 0 -TTGGGGGTAGGAACACGGAAGG-3 0 ), Myorg Forward 5 0 -CATGCCTGCCATGCAGTTTTC-3 0 and Reverse 5 0 -GTCGCCAGTGTCGGTGATCTC-3 0 . Real-time PCR of Myorg cDNA were performed using the LightCycler 480 Instrument II (Roche Applied Science) with the SYBR Green I Master kit (Roche, USA) following the manufacturer's instructions. Gene mRNA expression was normalized to the endogenous housekeeping gene GAPDH, and to the amount of heart samples using the quantitative method. This experiment was repeated three times to obtain mean ± SEM.
Histology
Control and Myorg KO mice anesthetized by pentobarbital were perfused with 4% PFA (pH 7.4). The brains were taken out and fixed in 4% PFA for another day before dehydration, and then embedded in paraffin. Sections with 4-mm thickness were prepared and mounted on Superfrost microscope slides. After deparaffinized in xylene and rehydrated, the brain sections were stained with alizarin red, H&E, Von Kossa, PAS and Alcian blue to assess calcium accumulation using standard protocols. For alizarin red staining, brain sections were incubated for 5 min in 2% alizarin red in 0.1 M Tris-HCL (PH 8.3) at room temperature. Three replications for each group were analyzed and the experimenters who performed the staining were blinded to the mice group.
SEM-EDS Analysis
The paraffin-embedded brain sections mounted on Superfrost microscope slides were examined on a scanning electron microscope (SEM, JSM-7800F, JEOL, Tokyo, Japan) equipped with an energy dispersive X-ray spectrometer (EDS, Thermos, Madison, WI, USA). Prior to scanning, the sections were coated with gold for 10 min using a Sputter coater and then attached to the specimen mounts by conductive resin. SEM scanning of the sections was performed with 10kV accelerating voltage to achieve images at 300 3 magnification. Calcified spheres and peripheral slice tissue were examined with the EDS and analyzed using automatic analyzer software to determine the elemental composition. In total, at least three calcified spheres from different KO mice were analyzed.
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